Howard Hughes Medical Institute scientists have simplified the chemical synthesis of small molecules, eliminating a major bottleneck that limits the exploration of a class of compounds offering ...

Scientists have leveraged fundamental features of chemical building blocks to transform chemical reaction analysis from minutes to milliseconds. The development of molecules to study and treat disease ...

Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical development while supporting pharma reshoring.

Daniel Blair, PhD, assistant member in the St. Jude Department of Chemical Biology and Therapeutics, and postdoctoral fellow Maowei Hu, PhD, at work in the lab. “Generality is essential for doing ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding EnodiaFinancing ...

Seed round co-led by Elaia, Pfizer Ventures and Bpifrance Machine-learning platform enables signal peptide-informed discovery ...